Aug 3, 2012 | Laboratory Hiring & Human Resources, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Sales and Marketing, Management & Operations
Medical labs and pathology groups using Sunquest LIS products likely to see positive changes from Sunquest’s fourth change in ownership since 2001
In what is likely to be the biggest deal in clinical laboratory and pathology informatics for this year, Roper Industries, Inc. (NYSE: ROP), of Sarasota, Florida, will acquire Sunquest Information Systems, Inc., of Tucson, Arizona. The purchase price is an impressive $1.42 billion dollars and the deal was announced on Monday this week.
Roper Industries will get a lot for its money. Sunquest holds a significant share of the nation’s market for laboratory information systems (LIS). Sunquest has also built a substantial market share in anatomic pathology informatics, anchored by its CoPath and PowerPath products.
Sales Price of $1.42 Billion for Sunquest and Its Clinical Lab Software
What some may consider an eye-popping sales price of $1.42 billion for Sunquest demonstrates that investor interest in all aspects of the clinical laboratory testing marketplace remains strong. In its second quarter conference call, executives at Roper Industries told the financial analysts that, during 2013, they expect Sunquest to generate $140 million in EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). If true, that would indicate that the sales price is based upon approximately a 10-times multiple of Sunquest’s EBIDTA. (more…)
Mar 26, 2009 | Digital Pathology, Laboratory News, Laboratory Pathology
Digital Pathology Imaging: Coming Soon to a Pathology Group near You!
Will pathologists soon say “sayonara” to glass slides? Plenty of smart money already bets the answer to that question is “yes”! Every pathologist in the United States and abroad should be watching developments in whole slide imaging and digital pathology systems. That’s because digital pathology imaging is a trend with momentum-and it also has the potential to be disruptive, although probably not in the short term.
One powerful sign that digital imaging in pathology is ready to go mainstream is the take-up of digital imaging solutions and digital pathology systems by leading pathology laboratories in the United States and developed countries across the globe. These are academic and tertiary center pathology labs, along with major private pathology companies. As the pathology profession’s first-movers and early adopters, it is these laboratories which set the pace for the entire profession. Their acceptance and growing use of digital imaging and digital pathology systems can be taken as evidence that the current generation of imaging and informatics technologies perform adequately.
However, there is another powerful force propelling digital imaging forward in anatomic pathology. It is the emergence of molecular assays which incorporate digital images and use either computer-aided diagnosis (CAD) or pattern recognition software to help the pathologist make a precise diagnosis. By design, these molecular tests require the pathologist to work from a digital image of the specimen. At The Dark Report‘s second annual Molecular Summit on the Integration of In Vivo and In Vitro Diagnostics, conducted last February in Philadelphia, examples of these types of emerging assays were abundant. (more…)